Novo Nordisk buys pair of biopharma companies
BAGSVAERD, Denmark — Novo Nordisk plans to acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Carmel, Ind. The Danish pharmaceutical company said Thursday that the acquisition will expand its portfolio of projects and intellectual property rights in the diabetes and obesity segments and help expand Novo Nordisk’s research presence
